3d
GlobalData on MSNThermo Fisher continues viral vector withdrawal; lays off 300 employeesThe cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.
Oxford, UK - 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the ...
Ever-Growing USA on MSN8h
Cell Line Development Process – Challenges and Best PracticesCell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.
2d
Stockhead on MSNAdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creationAdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.
GHz millimeter-wave antenna board Demonstration setup 60 GHz millimeter-wave wireless communications module First presenta ...
Unsurprisingly, my last two columns discussed artificial intelligence (AI), specifically the impact of language models (LMs) ...
Researchers are enhancing the best features of AAV capsids and overcoming their limitations to accelerate gene-based therapies.
Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...
3d
Pharmaceutical Technology on MSNItalian charity seeks EMA approval for rescued gene therapyTelethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results